secwatch.observer — SEC 8-K summary
======================================

Issuer:     IO Biotech, Inc. (IOBTQ)
CIK:        0001865494
Form:       8-K
Filed at:   2025-11-21T23:59:59+00:00
Accession:  0001193125-25-291504
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

IO Biotech chief accounting officer Burkavage resigns; CFO Sullivan to succeed
------------------------------------------------------------------------------

- Brian Burkavage resigns as SVP and Chief Accounting Officer effective December 12, 2025 to pursue another opportunity; no dispute with company.
- CFO Amy Sullivan designated as principal accounting officer upon Burkavage's departure; no new compensatory arrangements entered.
- Sullivan's biography previously disclosed in IO Biotech's April 2025 definitive proxy statement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1865494/000119312525291504/0001193125-25-291504-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1865494/000119312525291504/d74446d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-291504

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer